-+ 0.00%
-+ 0.00%
-+ 0.00%

ETON PHARMACEUTICALS - RETAINS COMMERCIAL RIGHTS TO ET-900 FOR PEDIATRIC NEUROLOGY

Reuters·11/02/2026 11:50:00

Please log in to view news